These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2291518)

  • 21. Agonist and antagonist characterization of the P2-purinoceptors in the guinea pig ileum.
    Wiklund NP; Gustafsson LE
    Acta Physiol Scand; 1988 Jan; 132(1):15-21. PubMed ID: 3223303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms.
    Boeynaems JM; Pearson JD
    Trends Pharmacol Sci; 1990 Jan; 11(1):34-7. PubMed ID: 2408210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct effects of adenylyl 5'-(beta,gamma-methylene)diphosphonate, a stable ATP analogue, on relaxant P1-purinoceptors in smooth muscle.
    Hourani SM; Bailey SJ; Nicholls J; Kitchen I
    Br J Pharmacol; 1991 Nov; 104(3):685-90. PubMed ID: 1797327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of norepinephrine release from vascular adrenergic nerves by adenyl purines.
    Shinozuka K; Bjur RA; Westfall DP
    Proc West Pharmacol Soc; 1988; 31():193-5. PubMed ID: 3211901
    [No Abstract]   [Full Text] [Related]  

  • 25. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.
    Verkhratsky A; Burnstock G
    Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology and pharmacology of the adenosine system.
    Di Perri T; Laghi-Pasini F
    Ann Ital Med Int; 1991; 6(4 Pt 2):442-7. PubMed ID: 1840810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photoaffinity labeling of a P3 purinoceptor-like protein purified from rat brain membranes.
    Saitoh Y; Nakata H
    Biochem Biophys Res Commun; 1996 Feb; 219(2):469-74. PubMed ID: 8605011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional evidence for involvement of P2 purinoceptors in the ATP stimulation of phosphatidylcholine secretion in type II alveolar epithelial cells.
    Gilfillan AM; Rooney SA
    Biochim Biophys Acta; 1988 Mar; 959(1):31-7. PubMed ID: 2830902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.
    Hoyle CH; Edwards GA
    Br J Pharmacol; 1992 Oct; 107(2):367-74. PubMed ID: 1422586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA; Hourani SM
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview. Purinergic mechanisms.
    Burnstock G
    Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic (P2) receptor-operated calcium entry into rat thyroid cells.
    Aloj SM; Liguoro D; Kiang JG; Smallridge RC
    Biochem Biophys Res Commun; 1993 Aug; 195(1):1-7. PubMed ID: 8363591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence in support of the P1/P2 purinoceptor hypothesis in the guinea-pig taenia coli.
    Brown CM; Burnstock G
    Br J Pharmacol; 1981 Jul; 73(3):617-24. PubMed ID: 6894712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerosis-related remodeling of aortic relaxation to purines in the Watanabe heritable hyperlipidemic rabbit.
    Ragazzi E; Chinellato A; Pandolfo L; Froldi G; Caparrotta L; Prosdocimi M; Aliev G; Fassina G
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1091-6. PubMed ID: 8355183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivity of equine tracheal smooth muscle to adenosine and some phosphorylated derivatives.
    Norris AA; Eyre P
    J Vet Pharmacol Ther; 1982 Sep; 5(3):199-201. PubMed ID: 6897267
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenosine-induced dilatation of the rabbit hepatic arterial bed is mediated by A2-purinoceptors.
    Mathie RT; Alexander B; Ralevic V; Burnstock G
    Br J Pharmacol; 1991 May; 103(1):1103-7. PubMed ID: 1878748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms.
    Rump LC; Oberhauser V; von Kügelgen I
    Kidney Int; 1998 Aug; 54(2):473-81. PubMed ID: 9690214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P1- and P2-purinoceptor subtypes--an update.
    Kennedy C
    Arch Int Pharmacodyn Ther; 1990; 303():30-50. PubMed ID: 2196860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting purinergic signaling for perioperative organ protection.
    Eltzschig HK
    Anesthesiology; 2013 May; 118(5):1001-4. PubMed ID: 23360900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.